Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Nxera Pharma Webinar Presentation for FY2025 Financial Results
Tokyo, Japan and Cambridge, UK, 26 January 2026 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for the year ended 31 December 2025 on Friday, 13 February 2026. The…
China halts sale of Sun Pharma drug used to treat dementia
China's medicine regulator has ordered a halt to the import, sale and usage of a drug used to treat dementia associated with Alzheimer's disease made by India's Sun Pharmaceutical Industries, according to an…
Sun Pharma, Cipla, Zydus, Graviti recall drugs in U.S. market
Drugmakers Sun Pharma, Cipla, Zydus and Graviti Pharmaceuticals are recalling different products in the U.S., most of them over manufacturing issues, according to latest U.S FDA enforcement reports. Sun Pharma is recalling 24,624 Fluocinolone…
13 stocks to watch today: PVR Inox, Marico, Sun Pharma, Cipla, ABB India & others
PVR Inox has sold its entire stake in the popcorn brand 4700BC, owned by Zea Maize. The multiplex cine major has sold its stake in Zea Maize to Marico for Rs 226.8 crore. PVR INOX had acquired a 70 per cent stake in Zea Maize for around Rs 5 crore…
Pharmalittle: We're reading about pharma lobbying, an FDA gene-editing pathway, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, despite the overwhelming winter storm that emerged, on this side of the pond, anyway. In any event, that oh-so-familiar routine…
Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 20,000 Shares of Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of the company's stock in a transaction on Friday, January 23rd. The shares were sold at an average price of $40.26, for a total transaction of $805,200.00.
Royalty Pharma PLC $RPRX Shares Sold by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd reduced its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 25.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 112,084…
Seoul to dispatch industry, trade ministers to US after Trump's tariff hike announcement
Korea's top industry and trade officials were headed to Washington on Tuesday to hold talks with their U.S. counterparts, as Seoul scrambles to contain the fallout from President Donald Trump's decision to raise tariffs on Korean goods from 15…
Trump says hiking tariffs on South Korean goods to 25%
U.S. President Donald Trump said Monday that he would raise tariffs on various South Korean goods, taking aim at the country for 'not living up to' an earlier trade pact struck with Washington. 'Because the Korean Legislature hasn't enacted our…
Trump Says He Will Raise Tariffs on South Korea to 25%
|Trump Says He Will Raise Tariffs on South Korea to 25% https://www.nytimes.com/2026/01/26/business/economy/trump-tariffs-south-korea.html President Trump threatened to increase tariffs on South Korean exports because the country had not ratified a…
Asia markets seeing 'unbelievable' rush of capital, driving equity rallies and IPO frenzy
The MSCI AC Asia Pacific Index rose to a fresh record high on Monday. 'Overall, Asia is just, it's unbelievable what activity we're seeing,' said Sjoerd Leenart, JPMorgan's Asia Pacific CEO. Liqun Liu | Construction Photography | Hulton Archive |…
Qualcomm backs SpotDraft to scale on-device contract AI with valuation doubling toward $400M
As demand grows for privacy-first enterprise AI that can run without sending sensitive data to the cloud, SpotDraft has raised $8 million from Qualcomm Ventures in a strategic Series B extension to scale its on-device contract review tech for…
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for its dual GLP-1/GIP receptor agonist CT-388 in people living with obesity
A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% (p < 0.001) at 48 weeks at the highest dose tested (24 mg), without reaching a weight loss plateau 54% of participants on…
Trump says he's hiking tariffs on South Korean goods to 25%
President Donald Trump said Monday that he was hiking tariffs on imports from South Korea to 25% from 15%, complaining that the nation's legislature wasn't 'living up' to a trade deal that was struck last year. 'Because the Korean Legislature…
Korea responds calmly to Trump's surprise tariff hike: Cheong Wa Dae
South Korea's presidential office said it would respond calmly to U.S. President Donald Trump's surprise announcement of higher tariffs, stressing its commitment to implementing bilateral trade agreements and maintaining close communication with…
Receive a Daily briefing on Pharma Industry News
Get Started